Prestige Consumer Healthcare Inc. to Release Fiscal 2022 Fourth Quarter and Year-End Earnings Results
14 avr. 2022 08h53 HE
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., April 14, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2022 fourth quarter and year-end earnings release on...
Prestige Consumer Healthcare Inc. Reports Fiscal 2022 Third Quarter Results
03 févr. 2022 06h00 HE
|
Prestige Consumer Healthcare Inc.
Revenue of $274.5 Million in Q3, up 14.9% versus Prior Year, up 8.8% on an Organic BasisDiluted EPS of $0.99 in Q3, up 22.2% versus Prior YearNon-GAAP Free Cash Flow of $64.1 Million for Third Quarter...
Prestige Consumer Healthcare Inc. to Release Fiscal 2022 Third Quarter Earnings Results
10 janv. 2022 16h30 HE
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2022 third quarter earnings release on Thursday,...
Prestige Consumer Healthcare Inc. Reports Fiscal 2022 Second Quarter Results
04 nov. 2021 06h00 HE
|
Prestige Consumer Healthcare Inc.
Record revenue of $276.2 Million in Q2, up 16.3% versus Prior Year, up 10.5% on an Organic BasisDiluted EPS of $0.89 and Adjusted Diluted EPS of $1.02 in Q2, up 30.8% versus Prior YearNet Cash...
Prestige Consumer Healthcare Inc. to Release Fiscal 2022 Second Quarter Earnings Results
06 oct. 2021 16h30 HE
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2022 second quarter earnings release on Thursday,...
Prestige Consumer Healthcare Inc. Reports Fiscal 2022 First Quarter Results
05 août 2021 06h00 HE
|
Prestige Consumer Healthcare Inc.
Revenue was $269.2 Million in Q1, up 17.3% versus Prior YearRecord Diluted EPS of $1.14 in Q1, up 32.5% versus Prior YearNet Cash Provided by Operating Activities of $69.3 million and Free Cash Flow...
Prestige Consumer Healthcare Completes Acquisition of TheraTears, Announces First Quarter Fiscal 2022 Earnings Results Date
01 juil. 2021 16h01 HE
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., July 01, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) (“Prestige“ or the “Company”) today announced that it has completed the previously announced...
Prestige Announces Agreement to Expand Eye Care Offering with Acquisition of TheraTears
27 mai 2021 08h30 HE
|
Prestige Consumer Healthcare Inc.
Acquisition adds TheraTears brand to Company’s leading eye care portfolioAcquisition expected to add approximately $60 and $20 million of Revenue and EBITDA, respectively on an annual basisTransaction...
Prestige Consumer Healthcare Inc. Reports Fiscal 2021 Fourth Quarter and Record Full-Year Results
06 mai 2021 06h00 HE
|
Prestige Consumer Healthcare Inc.
Company Exceeds Full Year 2021 Guidance for Revenue, Adjusted EPS and Free Cash FlowRevenue was $237.8 Million in Q4 and $943.4 in Full-Year Fiscal 2021Record Diluted EPS of $3.25 for Full-Year Fiscal...
Prestige Consumer Healthcare Inc. to Release Fiscal 2021 Fourth Quarter and Year-End Earnings Results
08 avr. 2021 08h00 HE
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., April 08, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 fourth quarter and year-end earnings release on...